相关实验视频
Updated: Jun 9, 2026

09:24
Decellularization and Recellularization of Whole Livers
Published on: February 4, 2011
22.0K
基于干细胞的策略:生物人工肝发育的未来方向
1Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China. fenglei10806@163.com.
Stem cell reviews and reports
|January 3, 2024
概括
由于供体器官稀缺,急性肝衰竭 (ALF) 治疗面临着挑战. 基于干细胞的生物人工肝 (BALs) 提供了一个有前途的替代方案,利用干细胞.
科学领域:
- 再生医学是一种再生医学.
- 肝病学 肝病学是一种肝病学.
- 生物技术是生物技术.
背景情况:
- 急性肝衰竭 (ALF) 是一种具有高死亡率的危急疾病,需要除了肝移植之外的有效治疗.
- 肝移植 (LT) 是ALF的唯一确定的治疗方法,但由于供体器官的供应有限而受到限制.
- 生物人工肝 (BAL) 设备为ALF提供了潜在的治疗策略,需要合适的细胞源.
研究的目的:
- 审查基于干细胞的策略在急性肝衰竭 (ALF) 中的生物人工肝 (BAL) 应用的现状和未来前景.
- 探索介质干细胞 (MSC) 和它们的秘密体作为BALs的替代细胞来源的潜力.
主要方法:
- 对最近关于干细胞在ALF的BAL应用的科学文献的综述.
- 分析介质干细胞 (MSC) 及其分泌物的特性,包括抗炎,免疫调节和再生的属性.
主要成果:
- 人类初级肝细胞虽然是理想的,但由于可用性和可行性问题而受到广泛使用BAL的限制.
- 干细胞,特别是MSC及其分泌体,表现出有利于ALF治疗的多方面的治疗特性.
- 这些特性包括抗炎性,免疫调节性,抗ROS性,抗亡性,前代谢性,抗纤维生成性和前再生性作用.
结论:
- 基于干细胞的策略,特别是使用MSC及其分泌物,显示出在ALF治疗中推进BAL技术的重大前景.
- 应对挑战并利用机遇对于这些基于干细胞的BAL策略的临床转化至关重要.
相关概念视频
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

